Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Labcorp Holdings Inc. (LH) P/B ratio

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/B ratio of 2.9×. Over the past ten years it has ranged from 1.2× (March 2020) to 3.3× (March 2015); the current reading is higher than 97% of that period. That is below the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 2.4× 1.34%
FY2024 2.4× (7.11%)
FY2023 2.6× 39.55%
FY2022 1.8× (27.46%)
FY2021 2.5× 40.92%
FY2020 1.8× (4.11%)
FY2019 1.9× 19.09%
FY2018 1.6× (24.75%)
FY2017 2.1× 1.66%
FY2016 2.1× (2.73%)

Quarterly

Period P/B ratio Change
Jun 2026 2.7× 5.65%
Mar 2026 2.5× 3.89%
Dec 2025 2.4× (11.72%)
Sep 2025 2.7× 6.15%
42 more quarters

Against its own ten years

Low 1.2× High 3.3×
Ten-year median 2.2×
Current reading's percentile 97

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on LH